|
AP4S1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.68480015996886E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.430200E-02 |
| Stage1-vs-Stage3 |
7.041700E-03 |
| Stage1-vs-Stage4 |
1.39950000477285E-08 |
| Stage2-vs-Stage3 |
2.039300E-03 |
| Stage2-vs-Stage4 |
3.4913999999997E-06 |
| Stage3-vs-Stage4 |
1.778170E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.15579945193201E-10 |
| Normal-vs-Asian |
1.65933933260476E-12 |
| Caucasian-vs-AfricanAmerican |
4.342800E-01 |
| Caucasian-vs-Asian |
7.723800E-02 |
| AfricanAmerican-vs-Asian |
6.481800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.070000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.07630000023562E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.611800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.447600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.741200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.742000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.174600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.957800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.46920000002149E-08 |
| Classical-VS-Follicular |
7.354100E-04 |
| Classical-VS-Other |
7.074800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
2.08429939974053E-11 |
| Tall-VS-Other |
1.560040E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.872570E-01 |
| Follicular-VS-Normal |
5.61983792835008E-12 |
| Other-VS-Normal |
1.59116999999265E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
3.166700E-04 |
|
|
